(Q37427243)

20 August 2017

1 reference

title

Gender differences in coronary artery disease: review of diagnostic challenges and current treatment (English)

1 reference

20 August 2017

0 references

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Prabhakaran Gopalakrishnan

series ordinal

1

1 reference

20 August 2017

Moluk Mirrasouli Ragland

series ordinal

2

1 reference

20 August 2017

Tahir Tak

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

20 August 2017

published in

Postgraduate Medicine

1 reference

20 August 2017

volume

121

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

60-68

1 reference

Evidence-based guidelines for cardiovascular disease prevention in women

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Outcomes of percutaneous and surgical revascularization in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Epidemiology of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

You've come a long way, baby: cardiovascular health and disease in women: problems and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Coronary heart disease: the female heart is vulnerable

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Impact of gender on mortality following primary angioplasty for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Diagnosis of coronary artery disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Cardiometabolic features of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Pathologic assessment of the vulnerable human coronary plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-T

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Treatment of acute myocardial infarction and 30-day mortality among women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Outcomes of thrombolytic therapy for acute myocardial infarction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Meta-analysis of exercise testing to detect coronary artery disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Noninvasive cardiac imaging with computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Accuracy of multislice computed tomography coronary angiography: a pooled estimate

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Hormones and heart disease in women: the timing hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Estrogen therapy and coronary-artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

Evaluating and Managing Cardiovascular Disease in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1977

21 January 2018

Identifiers

DOI

10.3810/PGM.2009.03.1977

1 reference

20 August 2017

1 reference